<DOC>
	<DOCNO>NCT01396226</DOCNO>
	<brief_summary>Medical Products Agency</brief_summary>
	<brief_title>A Multi-centre Study Comparing Effects AZD2927 Placebo Electrical Activity Heart Patients</brief_title>
	<detailed_description>- A Multi-Centre , Double-Blind , Randomised , Placebo-Controlled Phase II Study Assess Effects Atrial Ventricular Refractoriness Intravenous Infusion AZD2927 Patients Undergoing Invasive Electrophysiological Procedure . - The study adaptive design . In 1st dose group plan number randomise patient 24 . The tentative number randomise patient optional 2nd dose group 12 , 24 36 thus total maximum 60 patient randomise study .</detailed_description>
	<criteria>male postmenopausal female , age 20 80 year inclusive , clinical indication catheter ablation atrial flutter , history paroxysmal atrial flutter , without paroxysmal AF . Single episodes persistent atrial flutter AF require cardioversion exclude patient study , sinus rhythm randomisation , adequate anticoagulation antithrombotic treatment accord ESC guideline 2010 national guideline , cardioversion within 14 day randomisation , history stroke transient ischaemic attack ( TIA ) . History significant head trauma , epilepsy disorder increase risk seizure , QTcF &gt; 450 m &lt; 350 m measure sinus rhythm randomisation , history and/or sign clinically significant sinus node dysfunction . Sinus bradycardia ( 50 beat per minute le ) randomisation , personal family history Torsades de Pointes ( TdP ) , polymorphic ventricular tachycardia , long QT syndrome , short QT syndrome , Brugada syndrome , personal history sustain ( &gt; 30 ) monomorphic ventricular tachycardia .</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>November 2012</verification_date>
	<keyword>Atrial refractoriness</keyword>
	<keyword>cardiac electrophysiology</keyword>
	<keyword>IKACh</keyword>
</DOC>